tirzepatide launch date Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide Market Trends, Share and

Some people achieve their weight loss goals on a 5 mg or 10 mg dose, while others may need to go up to the maximum dose

In December 2025, the administration also introduced the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) model, a five year CMS Innovation Center (CMMI) model that intends to expand access to obesity drugs in Medicaid and Medicare by negotiating lower GLP-1 prices with manufacturers

During the delivery of Pluvicto, imaging can identify PSMA-positive tumors through a PET scan

The chemotherapy drug GEM further induces USP8 expression, leading to increased stability and expression of NRF2

Yet, insurance plans often require prior authorization for disbursing these medications

Quick response from the team regarding any questions